© 2021 MJH Life Sciences and HCPLive. All rights reserved.
© 2021 MJH Life Sciences™ and HCPLive. All rights reserved.
January 20, 2021
A spokesperson from American Red Cross discusses the importance of National Blood Donor Month and the challenges faced during the COVID-19 pandemic.
January 19, 2021
Dr. Matthew Brams presented new data showing the efficacy of CTx-1301 for ADHD.
January 18, 2021
CTx-1301's formulation enables 3 different doses within 1 pill for ADHD.
Researchers are prepared a phase 3 trial testing the treatment in adults with ADHD.
The role of many in psychiatry has changed during the COVID-19 pandemic.
January 17, 2021
A pair of researchers present plans to improve collaboration with other professionals in ADHD.
An ADHD coach can work on more goal-based plans for individuals with ADHD.
January 16, 2021
There is currently no approved treatment for fragile X syndrome.
Methylphenidate has shown promising boosting morning function in pediatric patients with ADHD.
The treatment improves morning function for adolescent ADHD patients.